Jan 31, 2022 7:30 am EST Elusys Therapeutics Finalizes HHS Contract to Deliver ANTHIM®, Its Treatment for Inhalation Anthrax, to the U.S. Department of Health and Human Services
Jan 12, 2022 8:00 am EST Heat Biologics Announces New PTX-35 Preclinical Data in Organ Transplantation and Provides Update on HS-110
Nov 30, 2021 7:30 am EST Heat Biologics Unveils RapidVax®, A Novel Cellular Vaccine Platform Targeting Known and Unknown Emerging Biological Threats
Oct 06, 2021 7:30 am EDT Heat Biologics Appoints Paul Tebbey as Senior Vice President of Product Development and Portfolio Strategy
Sep 15, 2021 7:30 am EDT Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th
Sep 09, 2021 8:30 am EDT Heat Biologics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference